Teva Pharmaceutical Industries (TEVA) News Today

Mackenzie Financial Corp cut its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 55.5% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 42,318 shares of the company's stock aft

Dimensional Fund Advisors LP raised its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 23.1% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,466,704 shares of the com

StockNews.com cut Teva Pharmaceutical Industries from a "strong-buy" rating to a "buy" rating in a research report on Thursday.

Truist Financial Corp raised its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 7.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,885,251 shares of the

MBB Public Markets I LLC boosted its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 413.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 78,598 shares of

Point72 Asset Management L.P. raised its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 38.0% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,319,217 shares of the company's stoc

Driehaus Capital Management LLC purchased a new position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 1,422,483 shares of the company's

Teva Pharmaceutical Industries Limited (NYSE:TEVA - Get Free Report) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 30,340,000 shares, an increase of 26.7% from the August 31st total of 23,950,000 shares. Based on an average trading volume of 8,710,000 shares, the short-interest ratio is currently 3.5 days.

Caxton Associates LP purchased a new position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 29,707 shares of

Lighthouse Investment Partners LLC purchased a new position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 420,000 shares of the company's stock,

Eminence Capital LP acquired a new position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 1,000,000 shares of the company's stock, valued at

Marshall Wace LLP trimmed its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 1.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,172,593 shares of the company's stock afte

Tri Locum Partners LP increased its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 15.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,550,307 shares of the company's stock a

Rubric Capital Management LP lessened its holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 2.3% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 17,261,741 shares of the company's stock after sel

Seven Eight Capital LP acquired a new position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 85,154 shares of the company's stock, valu

Lingotto Investment Management LLP raised its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 0.1% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 26,462,600 shares of the company's stock after buying an additional 38,0

Teva Pharmaceutical Industries (NYSE:TEVA) Trading Down 2.4%

Renaissance Technologies LLC grew its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 13.4% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8

Daiwa Securities Group Inc. trimmed its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 29.7% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 81,365 shares of the company's stock

Cornercap Investment Counsel Inc. purchased a new stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 64,514 shares of the company's stock, valued a

Commonwealth Equity Services LLC trimmed its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 39.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 162,770 shares of the compa

Victory Capital Management Inc. lifted its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 6.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,906,951 shares of the

Monaco Asset Management SAM trimmed its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 65.2% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 475,000 shares of the company's stock after selling 889,121 sh

Private Management Group Inc. lessened its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 6.3% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,375,431 shares of the company's stock afte

Bank of New York Mellon Corp trimmed its holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 2.0% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,602,213 shares of the company'

Teva Pharmaceutical Industries (NYSE:TEVA) Sets New 12-Month High on Analyst Upgrade